Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Pablo Carretero"'
Autor:
Xavier Filella, Juan Alcover, Pablo Carretero, Antonio M. Ballesta, Juan M. Corral, Rafael Molina
Publikováno v:
The Prostate. 42:181-185
BACKGROUND To enhance the specificity of PSA in diagnosis of cancer, several approaches have been evaluated, having in common the study of fractions of PSA. The aim of this study was to evaluate the usefulness of complexed PSA in the differential dia
Autor:
Juan Llopis, Miguel A. Barranco, Maria J. Ribal, Alfredo Rodríguez, Manel Solé, P J Ventura, Juan M. Corral, Antonio Alcaraz, Pablo Carretero
Publikováno v:
Scopus-Elsevier
Histological grade (G) is the only parameter proved to have prognostic value for progression in T1 transitional cell carcinoma (TCC) of the bladder, although it is considered inaccurate to make clinical decisions on individuals. The aim of the presen
Publikováno v:
American Journal of Clinical Oncology. 20:471-476
Bone metastases, together with generalized bone resorption, represent the main complication in patients with advanced prostate cancer, and palliative treatments are required to delay the progression of the metastases and improve the quality of life o
Autor:
Ricardo Alvarez-Vijande, Manuel Solé, Violeta Menéndez, Pablo Carretero, Xavier Sala, Alfredo Rodríguez
Publikováno v:
Urology. 50:31-37
Objectives To refine the clinical and radiologic description of an unusual benign disease, cystic pyeloureteritis (CPU), consisting of the appearance of suburothelial cysts that raise the mucosa layer of the urothelium. We also studied its relationsh
Autor:
Antonio M. Ballesta, Xavier Filella, Alfredo Rodríguez, Juan Alcover, Pablo Carretero, Rafael Molina
Publikováno v:
Tumor Biology. 18:332-340
The use of PSA in the diagnosis of prostate cancer is controversial. This is due to false-positive results caused by benign prostatic hyperplasia (BPH). Different forms of circulating PSA have recently been described. Initial studies indicate that th
Autor:
Rina Kashi, Xavier Filella, Yu-Hsueh Wang, Marianne Grob, Pablo Carretero, Yoshikazu Hayatsu, Yoshihisa Fujikura, Rafael Molina, Keith Sides, Paul M. Sondel, Rosalyn D. Blumenthal, David M. Goldenberg, Sallie S. Boggs, Fumihiko Shinozaki, M. Deutsch, Rhona Stein, Xinwei Li, Tetsuo Fukumoto, Rehana Sultana Lovely, Nobuko Tokuda, Dawn H. Siegel, Patrizia Lorenzoni, E.S. Redgate, Antonio M. Ballesta, Max M. Burger, C.M. Nicolet, Dorit Goren, Alfredo Rodríguez, Tomoo Sawada, J.E. Surfus, Juan Alcover, A. Gabryel-Grudziak, Robert M. Sharkey
Publikováno v:
Tumor Biology. 18:I-IV
Publikováno v:
International Journal of Cancer. 68:424-427
Prostate-specific antigen (PSA) has been characterized as a specific prostate marker, although recent studies have suggested the existence of PSA of nonprostatic sources. We have assessed the presence of PSA by an ultrasensitive assay in 276 serum an
Autor:
Antonio M. Ballesta, Pablo Carretero, Nuria Giménez, Xavier Filella, Juan Alcover, Violeta Menéndez, Judith Jo, Rafael Molina
Publikováno v:
The Prostate. 29:311-316
BACKGROUND The Prostate Specific Antigen (PSA) has been characterized as a specific prostate marker. Recent studies have indicated the existence of a PSA of nonprostatic origin detected in lactating women and breast tumors. METHODS We have evaluated
Publikováno v:
The Journal of Urology. :2001-2004
Purpose: We evaluated the urodynamic changes produced by insulin-dependent diabetes mellitus with end stage renal disease.Materials and Methods: A urodynamic evaluation was performed on 51 young patients (mean age plus or minus standard deviation 35
Autor:
Pablo Carretero, Juan Alcover, Walter Carrere, Antonio M. Ballesta, Xavier Filella, Rafael Molina
Publikováno v:
Tumor Biology. 17:20-26
To evaluate the diagnostic usefulness of prostate-specific antigen density (PSAD) in prostate cancer (PC) prostate-specific antigen (PSA) concentrations were measured in 175 patients with benign prostatic hypertrophy (BPH) and 50 patients with PC. Pa